Hyundai Bioscience

048410.KQ

9.81 USD

-0.37

-3.63%

Overview

Last close

9.81 usd

Market cap

942.31M usd

52 week high

13.86 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

720.1816

Price/Book Value

12.8012

Enterprise Value

918.39M usd

EV/Revenue

705.2049

EV/EBITDA

-64.6317

Key financials

Revenue TTM

1.30M usd

Gross Profit TTM

54040.18 usd

EBITDA TTM

-10.21M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

83.26M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.